Snowball logo
logo
  • Stocks
  • Other
  • Healthcare
6883

Shanghai MicuRx Pharmaceutical Co. Ltd. A

688373 • SHG
¥5.62¥0.00  (0%)
Estimate
EPS
-0.22
Beta
0.379
Growth
Revenue, YoY
28.58%
Net income, YoY
85.64%
FCF, YoY
89.62%
About the company
Ticker
688373
ISIN
CNE100005PX4
Country
Other
Sector (GICS)
Healthcare
Shanghai MicuRx Pharmaceutical Co., Ltd., a biopharmaceutical company, discovers, develops, and commercialize drugs for unmet medical needs. It is developing Contezolid (MRX-I) and Contezoilid acefosamil (MRX-4) oxazolidinone antibiotics for multidrug-resistant gram-positive bacteria; MRX-8 MRX, a polymyxin antibiotic, to target multidrug-resistant Gram-negative bacteria; MRX-5 for multidrug-resistant gram-negative bacteria; MRX-7 for multidrug-resistant gram-positive bacteria; MRX-15 and MRX-17 to treat kidney disease; MRX-18 for the treatment of COVID-19; and MRX-23 for the treatment of tumour. The company was founded in 2007 and is based in Shanghai, China.

Frequently asked questions

What sector does Shanghai MicuRx Pharmaceutical Co. Ltd. A (688373) operate in?

Shanghai MicuRx Pharmaceutical Co. Ltd. A belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Shanghai MicuRx Pharmaceutical Co. Ltd. A (688373) current stock price?

As of the latest data, Shanghai MicuRx Pharmaceutical Co. Ltd. A stock price is CN¥5.62, with a previous close of CN¥5.62.

What is Shanghai MicuRx Pharmaceutical Co. Ltd. A (688373) current market capitalization?

Shanghai MicuRx Pharmaceutical Co. Ltd. A market cap is approximately 3.69 billion.

What is Shanghai MicuRx Pharmaceutical Co. Ltd. A (688373) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.22.

Does Shanghai MicuRx Pharmaceutical Co. Ltd. A (688373) pay dividends?

No. Shanghai MicuRx Pharmaceutical Co. Ltd. A does not pay a dividend.

What is Shanghai MicuRx Pharmaceutical Co. Ltd. A (688373) beta (volatility) score?

Shanghai MicuRx Pharmaceutical Co. Ltd. A has a beta of 0.379, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsSnowball Analytics MCPPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.